Home About Science Investors & Partners Our people News & Events Careers Contact us Contact us Telephone: +44 (0)1223 867 900 Email: info@artiospharma.com 7  Artios Pharma, Babraham Research Campus B940 Babraham Research Campus Cambridge, CB223FH UK  Artios Pharma Inc 33 West 60th Street, #1115, New York, NY 10023 US General enquiries: info@artiospharma.com +44 (0)1223 867 900 Quick links Home About Science Our team News & events Contact us Contact Telephone: +44 (0)1223 867 900 General enquiries: info@artiospharma.com Careers: HR@artiospharma.com Finance: Accounts@artiospharma.com Our career opportunities Our careers © Artios Pharma 2019 Terms & conditions | Privacy policy | Site map We use cookies to collect data, please see our privacy policy.

Home About Science Investors & Partners Our people News & Events Careers Contact us News & Events FOLLOW OUR PROGRESS 7 All Press release Media coverage Conferences Listen to our CEO and CSO talk at the Northland Synthetic Lethality Conference – Nov 17 2021 December 2, 2021 CONFERENCES Artios Appoints Nora Brennan to Board of Directors and Audit Committee Chair November 16, 2021 PRESS RELEASE Artios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215 September 28, 2021 PRESS RELEASE More exciting press coverage following $153 Million financing – Series C August 27, 2021 MEDIA COVERAGE Artios Announces $153 Million (£110 Million) Series C Financing Led by Omega Funds and TCG X July 27, 2021 PRESS RELEASE Exciting press coverage following our Polθ (Pol-theta) press release – Nature Communications July 1, 2021 MEDIA COVERAGE Our press coverage following our Novartis collaboration July 1, 2021 MEDIA COVERAGE Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications June 17, 2021 PRESS RELEASE Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies April 7, 2021 PRESS RELEASE Artios Pharma to Attend Upcoming Conferences in February and March 2021 February 18, 2021 PRESS RELEASE Niall Martin, Chief Executive Officer presented a company overview at LifeSci Partners Precision Oncology Day February 17, 2021 CONFERENCES Dr Graeme Smith presents at Medicine at The Crick – 11 February 2021 February 11, 2021 CONFERENCES Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients February 11, 2021 PRESS RELEASE Medicine at The Crick – Thursday 11 February. Dr Graeme Smith is giving a talk. February 5, 2021 ANNOUNCEMENT Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer January 12, 2021 PRESS RELEASE Quick links Home About Science Our team News & events Contact us Contact Telephone: +44 (0)1223 867 900 General enquiries: info@artiospharma.com Careers: HR@artiospharma.com Finance: Accounts@artiospharma.com Our career opportunities Our careers © Artios Pharma 2019 Terms & conditions | Privacy policy | Site map We use cookies to collect data, please see our privacy policy.